IP20-23: Spectrum of BCG-Related Adverse Events Predicts Oncologic Outcomes in Non–Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study

IP20-23: Spectrum of BCG-Related Adverse Events Predicts Oncologic Outcomes in Non–Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!